Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9EBD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,540
Award facts
- Contract value 100% obligated
- $29,539.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $29,539.99 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units), with an ultimate completion date of February 2, 2026. This is a non-set-aside contract awarded on a competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a subsidiary of parent company Cencora, Inc. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026 and serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen's IDC with DLA encompasses a broad spectrum of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This delivery order for Arimidex, an aromatase inhibitor used in breast cancer treatment, exemplifies the company's role as a critical vendor in the federal medical procurement supply chain, serving Defense Health Agency programs, the U.S. Coast Guard, and other government healthcare systems. The competitive award demonstrates AmerisourceBergen's continued capability to meet federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F9EBD?
SPE2DR26F9EBD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9EBD worth?
The government has obligated $29,540 on SPE2DR26F9EBD.
Is contract SPE2DR26F9EBD an order under another contract?
Yes. SPE2DR26F9EBD is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EBD competed?
The extent of competition for SPE2DR26F9EBD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award